Effect of Pre- and Postnatal Manganese Exposure on Brain Histamine Content in a Rodent Model of Parkinson’s Disease
- 170 Downloads
Rats lesioned shortly after birth with 6-hydroxydopamine (6-OHDA; 134 μg icv) represent a near-ideal model of severe Parkinson’s disease because of the near-total destruction of nigrostriatal dopaminergic fibers. There are scarce data that in Parkinson’s disease, activity of the central histaminergic system is increased. The element manganese, an essential cofactor for many enzymatic reactions, itself in toxic amount, replicates some clinical features similar to those of Parkinson’s disease. The aim of this study was to examine the effect of neonatal manganese exposure on 6-OHDA modeling of Parkinson’s disease in rats, and to determine effects on histamine content in the brain of these rats in adulthood. Manganese (MnCl2·4H2O; 10,000 ppm) was included in the drinking water of pregnant Wistar rats from the time of conception until the 21st day after delivery, the age when neonatal rats were weaned. Control rats consumed tap water. Other groups of neonatal rat pups, on the 3rd day after birth, were pretreated with desipramine (20 mg/kg ip 1 h) prior to bilateral icv administration of 6-OHDA (60 or 134 μg) or its vehicle saline–ascorbic (0.1%) (control). At 2 months after birth, in rats lesioned with 60 or 134 μg 6-OHDA, endogenous striatal dopamine (DA) content was reduced, respectively, by 92 and 98% (HPLC/ED), while co-exposure of these groups to perinatal manganese did not magnify the DA depletion. However, there was prominent enhancement of histamine content in frontal cortex, hippocampus, hypothalamus, and medulla oblongata of adult rat brain after 6-OHDA (60 and 134 μg) injection on the day 3rd postnatal day. These findings indicate that histamine and the central histaminergic system are altered in the brain of rats lesioned to model Parkinson’s disease, and that manganese enhances effects of 6-OHDA on histamine in brain.
KeywordsManganese 6-Hydroxydopamine Histamine Brain Rats
This study was supported from the Polish Ministry of Science and Information, grant no: 3298/B/P01/2007/33. Authors express their thanks to Mrs. Urszula Mikołajun and Barbara Mędrek for their excellent assistance.
- Aschner M, Kimelberg HK (1996) Astrocytes: potential modulators of heavy metal-induced neurotoxicity. In: Chang LW (ed) Toxicology of metals. Lewis Publisher, London, pp 587–608Google Scholar
- Brus R, Kostrzewa RM, Perry KW, Fuller RW (1994) Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. J Pharmacol Exp Ther 260:231–237Google Scholar
- Brus R, Szkilnik R, Konecki J, Stepien M, Malecki S, Kuballa G, Mengel K, Shani J (2002b) Prenatal exposure of rats to manganese: changes in reactivity of their central dopaminergic, serotoninergic and muscrine receptors, but not of glucose uptake in their adult offsprings. Pharmacol Rev Commun 12:9–24CrossRefGoogle Scholar
- Davidson L, Cederblad A, Lonnerdal B, Sandstrom B (1989) Manganese absorption from human milk, cow’s milk and infant formulas in humans. Am J Dis Child 143:823–827Google Scholar
- Inoue N, Makita Y (1996) Neurological aspects in human exposure to manganese. In: Chang LW (ed) Toxicology of metals. Lewis Publisher, London, pp 415–438Google Scholar
- Kostrzewa RM (2001) Mechanism of action of 6-hydroxydopamine, a dopaminergic neurotoxin. In: Segura-Aguilar J (ed) Mechanisms of degeneration and protection of the dopaminergic system. FP Graham Publishing Co., Johnson, pp 89–104Google Scholar
- Kostrzewa RM, Gong L, Brus R (1992) Serotonin (5-HT) systems mediate dopamine (DA) receptor supersensitivity. Acta Neurobiol Exp 53:31–41Google Scholar
- Seth PK, Husain R, Mishtag M, Chandro SV (1997) Effect of manganese on neonatal rat: manganese concentration and enzymatic alterations in brain. Acta Pharmacol Toxicol 40:553–560Google Scholar
- Tanaka S, Lieben J (1969) Manganese poisoning and exposure in Pennsylvania. Arch Environ Health 19:647–684Google Scholar
- Wagner J, Vitali P, Palfreyman MG, Zraika M, Hout S (1982) Simultaneous determination of 3,4-dihydroxyphenylalanine, 5-hydroxytryptophan, dopamine, 4-hydroxy-3-MPA, NE, 3,4-dihydroxyphenylacetic acid, homovanillic acid, serotonin, and 5-HIAA in rat cerebrospinal fluid and brain by HPLC. J Neurochem 38:1241–1254PubMedCrossRefGoogle Scholar